Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by rad10on Oct 13, 2016 8:13am
51 Views
Post# 25338372

RE:Photofrin could produce revenue in excess of 100 million

RE:Photofrin could produce revenue in excess of 100 million Always been excited at the prospect of photodynamic therapy - especially with the skin cancer epidemic amongst boomers across North America - unfortunately the indication at the moment is for cholangiocarcinoma which is rather rare and the therapy is confined to experimental studies in teaching centers.  

Its also indicated for esophageal and non small cell lung but use is not widespread.  PDT has so much potential - but like nuclear fusion and the hydrogen car - the widespread acceptance is always a few years away.....................
<< Previous
Bullboard Posts
Next >>